Cart
sales@molnova.com
DCLX069
CAS No. 792946-69-1
DCLX069( DCLX-069 | DCLX 069 )
Catalog No. M27868 CAS No. 792946-69-1
DCLX069 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 value of 17.9 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 41 | Get Quote |
|
| 5MG | 65 | Get Quote |
|
| 10MG | 102 | Get Quote |
|
| 25MG | 176 | Get Quote |
|
| 50MG | 290 | Get Quote |
|
| 100MG | 462 | Get Quote |
|
| 500MG | 981 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDCLX069
-
NoteResearch use only, not for human use.
-
Brief DescriptionDCLX069 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 value of 17.9 μM.
-
DescriptionDCLX069 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 value of 17.9 μM. DCLX069 occupies the SAM binding pocket to exert the inhibitory effect. DCLX069 effectively blocks cell proliferation in breast cancer, liver cancer, and acute myeloid leukemia cell lines.
-
In Vitro——
-
In Vivo——
-
SynonymsDCLX-069 | DCLX 069
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorDNA alkylator
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number792946-69-1
-
Formula Weight339.44
-
Molecular FormulaC20H25N3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (294.61 mM)
-
SMILESO=C(OCC)C1=CC=C(N2CCN(CC3=CC=CC=C3)CC2)C(N)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.D T Beranek. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat Res. 1990 Jul;231(1):11-30.
molnova catalog
related products
-
KDM1A-IN-29
KDM1A-IN-29 is a histone demethylase inhibitor.
-
GSK 690
GSK 690 is an irreversible, mechanism based inhibitor of lysine specific demethylase 1 (LSD1) with IC50 of 77 uM.
-
JQKD82
JQKD82 is a selective inhibitor of KDM5 and increases H3K4me3. JQKD82 can be used in studies about the treatment of multiple myeloma.
